Read-only by design — Olmem never buys, sells, shorts, or places any order. This platform provides market research and decision-support tools only. It does not provide personalized financial advice, does not guarantee investment results, and does not execute trades. All investment decisions are the responsibility of the user.
O
← Scanner

JNJJohnson & Johnson

Healthcare·Drug Manufacturers·NYSE·Mkt cap $360.00B
$257.86
$0.93 (+0.36%) today
IEX feed · not consolidated
Last updated Jul 14, 8:41 PM
68/100 Opportunity
18Risk
79Momentum
55Pullback
73Quality
78Valuation
100Trend
Price & History (up to 5 years)
2025-09-11 → 2026-09-11
Low 170.36— support · — resistanceHigh 278.45
Technical Indicators
RSI (14)60.6
MACD hist0.39
ATR (14)5.56
SMA 20248.89
SMA 50236.27
SMA 200219.62
Rel volume0.8x
Boll upper272.64
Boll lower225.14
52w high269.40
52w low151.04
5y high269.40
5y low133.78
Hist. vol18%
Max drawdown-11%
Long-Term UptrendStrong Momentum WatchWait for ConfirmationEntry: Pullback Watch
Company QualityDividend Compounder
Revenue growth+4.0%
Earnings growth+5.0%
Profit margin+20.0%
ROE+25.0%
Debt/Equity0.45
Free cash flow$18.00B
P/E15.0
Fwd P/E14.0
P/S4.3
P/B5.5
Div yield+3.1%

Pharmaceuticals and medical devices.

Decision SummaryInternal Rule-Based Analysis
Current Rating
Neutral / Needs Confirmation
Opportunity Score
68/100
Risk Level
Low
Best Action
Add to watchlist and monitor for confirmation

Why: JNJ is trading near recent levels (+0.4% today). Overall, the company is reasonably solid. The long-term trend remains up. Price is holding above key moving averages with constructive structure. This may be worth monitoring, but confirmation is needed before acting.

What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.

Avoid if: Price breaks below support on heavy volume or company guidance weakens.

Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.

Research only — not financial advice. Olmem never executes trades.

All Scores
Company Quality73
Historical Context58
Valuation78
Trend100
Momentum79
Pullback55
News Sentiment50
Business Move50
Sector Strength55
Risk/Reward61
Entry Timing55
Sell Risk20
Risk18

News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.

Recent NewsLive headlines

Real headlines from across the web. By default Olmem reads them with its rule-based news engine (keyword-classified — no AI) to set the News Sentiment score. Connect your own AI provider to have it read these actual headlines in the AI Stock Explanation.